Prognostic factors and prognostic models for renal cell carcinoma: a literature review
T Klatte, SH Rossi, GD Stewart - World journal of urology, 2018 - Springer
Purpose Following curative treatment for localised renal cell carcinoma (RCC), up to 30% of
patients develop tumour recurrence. Prognostic scores are essential to guide individualised …
patients develop tumour recurrence. Prognostic scores are essential to guide individualised …
[HTML][HTML] Potential clinical applications of microRNAs as biomarkers for renal cell carcinoma
Results MicroRNAs are essential regulators of various processes such as cell proliferation,
differentiation, development and death; they have been implicated in diverse biological and …
differentiation, development and death; they have been implicated in diverse biological and …
KIM-1 as a blood-based marker for early detection of kidney cancer: a prospective nested case–control study
Purpose: Renal cell carcinoma (RCC) has the potential for cure with surgery when
diagnosed at an early stage. Kidney injury molecule-1 (KIM-1) has been shown to be …
diagnosed at an early stage. Kidney injury molecule-1 (KIM-1) has been shown to be …
MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma
Introduction Currently, there is no accurate diagnostic molecular biomarker for renal cell
carcinoma (RCC). The aim of this study was to assess the expression of microRNA-15a (miR …
carcinoma (RCC). The aim of this study was to assess the expression of microRNA-15a (miR …
[HTML][HTML] Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma
W Kassouf, LL Monteiro, DE Drachenberg… - Canadian Urological …, 2018 - ncbi.nlm.nih.gov
Methods A systematic search of the PubMed and MEDLINE databases was conducted. The
searches were limited to English-language publication. The main search terms used to …
searches were limited to English-language publication. The main search terms used to …
Differences in urinary amino acid patterns in individuals with different types of urological tumor urinary amino acid patterns as markers of urological tumors
K Duskova, S Vesely, JDC Silva, N Cernei, O Zitka… - in vivo, 2018 - iv.iiarjournals.org
Background: Insufficient specificity and invasiveness of currently used diagnostic methods
raises the need for new markers of urological tumors. The aim of this study was to find a link …
raises the need for new markers of urological tumors. The aim of this study was to find a link …
[HTML][HTML] Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
PJ Selby, RE Banks, W Gregory, J Hewison… - 2018 - europepmc.org
Background Protein biomarkers with associations with the activity and outcomes of diseases
are being identified by modern proteomic technologies. They may be simple, accessible …
are being identified by modern proteomic technologies. They may be simple, accessible …
Development of analytical tools for quantification and screening for inhibitors of glutamate carboxypeptidases II and III
V Navrátil - 2018 - dspace.cuni.cz
Glutamate carboxypeptidase II (GCPII) usually called prostate specific membrane antigen
(PSMA) is membrane bound metallopeptidase expressed mainly in prostate carcinoma …
(PSMA) is membrane bound metallopeptidase expressed mainly in prostate carcinoma …
[PDF][PDF] Guide de pratique de l'Association des urologues du Canada pour le suivi des patients après le traitement d'un carcinome à cellules rénales non métastatique
W Kassouf, LL Monteiro, DE Drachenberg, AS Fairey… - CUAJ, 2018 - cua.org
Le carcinome à cellules rénales (CCR) représente environ 3% de tous les cas de cancer.
Ce cancer est environ deux fois plus fréquent chez les hommes que chez les femmes; chez …
Ce cancer est environ deux fois plus fréquent chez les hommes que chez les femmes; chez …
Preliminary Metabolomic Study of Urine Samples in Patients Affected by Renal Clear Cell Cancer by GC-MS
P Caboni - INTERNATIONAL JOURNAL OF CLINICAL UROLOGY, 2018 - iris.unica.it
Renal cell carcinoma (RCC) represent 2-3% of all cancers. Currently, there are no invasive
screening tests that could help to find diagnosis and possible follow up in clinical practice …
screening tests that could help to find diagnosis and possible follow up in clinical practice …